Bucharest Oncology Institute Accused of Diverting Chemotherapy Drugs to Private Clinics

The revelations from outgoing Health Minister Alexandru Rafila paint a grim picture of corruption within Romania's healthcare system, specifically at the Bucharest Oncology Institute. The discovery of chemotherapy drugs being systematically stolen and rerouted to private clinics, facilitated by fictitious invoices and a lack of proper accounting, is not just a financial scandal but a betrayal of public trust.

“

The chemotherapy drugs were stolen from IOB and taken to private hospitals where some doctors worked.

This situation, as highlighted by Rafila, points to a deeply entrenched problem, with the current management inheriting a legacy of mismanagement and illicit activity. The fact that a PET-CT scanner, funded by the Ministry of Health, was underutilized while a private facility nearby served patients from the institute, raises serious questions about conflicts of interest and the prioritization of profit over patient care.

“

There are invoices entered into the hospital, but without medications entering the hospital. So, fictitious invoices.

While the minister assures that the issues are being investigated and will be handed over to the prosecutor's office, the public's confidence in the healthcare system has undoubtedly been shaken. This incident underscores the urgent need for greater transparency, accountability, and stringent oversight within public health institutions to prevent such egregious abuses from recurring. The focus must remain on ensuring that vital medications reach the patients who desperately need them, rather than lining the pockets of corrupt individuals.

“

The report of the Court of Accounts is from the period 2023-2024. The manager who is currently in office, I believe she was appointed exactly in that period, and it is a legacy inherited from the former leadership, which has since been rectified.